Why the study?
Are serum carotenoid and retinoid levels, or dietary intakes, altered in individuals with obesity or metabolic diseases compared to healthy controls?
Are serum carotenoid and retinoid levels, or dietary intakes, altered in individuals with obesity or metabolic diseases compared to healthy controls?
Individuals with obesity or metabolic diseases have significantly lower serum carotenoid levels compared to healthy controls, suggesting a potential physiological role in disease development.
Answers are grounded in this paper and cite their sources.
Lower carotenoid levels may warrant nutritional assessment in obesity; confirms inverse association and extends observational evidence for trials.
This review summarises the association between serum carotenoids, serum retinoids and dietary intake outcomes with obesity/overweight and individuals with metabolic diseases with disturbances in lipid metabolism. Observational studies reporting dietary intakes and serum concentrations of carotenoids and retinol were collected from Medline and Web of Science. Mean differences were calculated between “cases” (classified as obese, overweight or having a metabolic disease with disturbances in lipid metabolism; i.e. non-alcoholic fatty liver disease, type 2 diabetes, dyslipidaemia or metabolic syndrome) and “comparator group” (classified as normal weight healthy individuals) and summarised in meta-analyses. Significant summary measures were observed for most serum provitamin A and non-provitamin A carotenoids. Studies reporting total serum carotenoids had shown the greatest decrease (–0.28 µmol/l [–0.33, −0.23], p<.001, I2=62.5%, n = 7). There were no significant summary measures for dietary outcomes, suggesting a physiological role of low serum carotenoids in the development of obesity and associated diseases.
No takes yet. Share an insight, caveat, or question.
Iqbal et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: